Related Experiment Video
Updated: Jul 18, 2026
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
[Inoperable valve disease: should percutaneous valve replacement be an option?]
1Mount Sinai Medical Center, New York, NY 10029-6574, USA.
Revista Espanola De Cardiologia
|December 21, 2006
Summary
Percutaneous valve replacement offers a new option for patients with severe aortic stenosis who are too high-risk for surgery. While still developing, this minimally invasive approach shows promise, especially for aortic valves, despite challenges with elderly, high-morbidity patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Context:
- Severe valvular heart disease poses significant risks, especially for patients with low inotropic reserve or those deemed inoperable due to high surgical mortality.
- Surgical valve replacement, while standard, is contraindicated in a substantial patient subset (approx. 15% with aortic stenosis) due to prohibitive surgical risks.
- Percutaneous balloon valvuloplasty provides palliative care but lacks the definitive benefits of valve replacement.
Purpose:
- To evaluate the safety and efficacy of percutaneous valve replacement as a novel therapeutic option for severe valvular heart disease.
- To assess the advancements in percutaneous valve replacement techniques and prosthesis materials since its inception.
- To analyze the challenges and potential of percutaneous valve replacement, particularly in high-risk and elderly patient populations.
Summary:
- Percutaneous valve replacement has emerged as a viable alternative to surgery for severe aortic stenosis, especially in patients unsuitable for traditional procedures.
- Technological advancements have refined percutaneous valve replacement techniques and prosthesis designs, though challenges remain in evaluating its long-term safety and efficacy.
- While initial studies faced setbacks, particularly in the US, international data suggest a positive future, with most deaths unrelated to valvular function. Results for mitral valve replacement remain suboptimal.
Impact:
- Percutaneous valve replacement is establishing itself as a crucial alternative for treating inoperable aortic valve disease, offering hope for improved patient survival and quality of life.
- Ongoing research and development are critical for overcoming the challenges associated with percutaneous valve replacement in complex patient profiles.
- The technique's success in aortic stenosis highlights the potential for minimally invasive solutions in valvular heart disease, driving innovation in cardiovascular interventions.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...